Lucentis(®) using Visudyne(®) study: determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration

PURPOSE: Combination verteporfin photodynamic therapy (vPDT) and antivascular endothelial growth factor (anti-VEGF) therapy may decrease the need for injections while maintaining visual acuity in exudative age-related macular degeneration. This pilot study was designed to determine the threshold flu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Eric, Brown, David M, Wong, Tien P, Benz, Matthew S, Kegley, Eric, Cox, Joel, Fish, Richard H, Kim, Rosa Y
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952607/
https://www.ncbi.nlm.nih.gov/pubmed/20957143
http://dx.doi.org/10.2147/OPTH.S13969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2952607/
https://www.ncbi.nlm.nih.gov/pubmed/20957143
http://dx.doi.org/10.2147/OPTH.S13969

Ejemplares similares